ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3227

Modelling Primary Sjögren’s Syndrome Using Salivary Gland Stem Cells

Sarah Pringle1, Hendrika Bootsma2, Arjan Vissink3, Fred K.L. Spijkervet4, Robert Coppes5 and Frans G.M. Kroese6, 1Rheumatology and Clinical Immunology, University Medical Centrum Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands, 3Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Radiation Oncology and Cell Biology, University Medical Centrum Groningen, Groningen, Netherlands, 6Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoimmune diseases and stem cells, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Sjögren's Syndrome II: Basic Insights

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Primary Sjögren’s Syndrome (pSS) is characterized by lymphocytic infiltration of salivary glands.  Unclear interactions between infiltrating cells and salivary gland ductal cells cause reduced gland function (hyposalivation), and significant decrease in patient quality of life. We recently isolated salivary gland stem cells from healthy human salivary gland biopsies, and characterized their self-renewal and differentiation capabilities. These stem cells are ductal cells and are therefore likely to be complicit in pSS manifestation. We sought to elucidate differences in salivary gland stem cells from pSS patients, compared to healthy controls. 

Methods: Salivary gland stem cells were isolated as published from parotid gland biopsies of healthy control and pSS patients [1]. After 4 days, stem cells, grown as balls of cells termed ‘salispheres’, were dispersed into single cells and new salispheres generated. This passaging was repeated to ascertain the proliferative potential. Every week, culture medium samples were taken for mass spectrometry analysis. Immunohistochemistry stainings and electron microscopy were performed as standard.

Results: Yield of salivary gland stem cells from pSS biopsies was significantly lower than from healthy control tissues. The self-renewal capability of stem cells from pSS biopsies was markedly reduced compared to healthy control samples (Fig. 1). Secretome analysis via mass spectrometry revealed an abundance of keratins in culture medium, suggesting expulsion/secretion/mislocalization of keratins by ductal cells in pSS (Fig. 2). In preliminary data,  ductal cells cytoplasm from pSS biopsies contained less  keratins. Keratin fibers were observed extracellularly basally to pSS ductal cells  by electron microscopy. 

Conclusion: Our data demonstrates that there is an innate difference in regenerative potential and secretome of salivary gland stem cells from pSS biopsies compared to healthy controls. This deficit suggests an innate defect in stem cell ability to regenerate damaged glandular tissue in pSS, and may hereby contribute to the hyposalivation. We suggest for the first time that expulsion, secretion or mislocalization of keratins may underpin salivary gland stem cell  defects in pSS and provide a novel insight into how salivary gland malfunction is manifested in pSS. Further characterization of stem cells from pSS biopsies, including  organoid generation (mini salivary glands-in-a-dish), will further reveal mechanisms underpinning ductal cell involvement in pSS, and generate new therapeutic options.

 


Disclosure: S. Pringle, None; H. Bootsma, None; A. Vissink, None; F. K. L. Spijkervet, None; R. Coppes, None; F. G. M. Kroese, None.

To cite this abstract in AMA style:

Pringle S, Bootsma H, Vissink A, Spijkervet FKL, Coppes R, Kroese FGM. Modelling Primary Sjögren’s Syndrome Using Salivary Gland Stem Cells [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/modelling-primary-sjogrens-syndrome-using-salivary-gland-stem-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/modelling-primary-sjogrens-syndrome-using-salivary-gland-stem-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology